Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 24 | 2025 | 110 | 5.920 |
Why?
|
| Air Pollution | 18 | 2024 | 71 | 4.380 |
Why?
|
| Maternal Exposure | 22 | 2025 | 145 | 3.710 |
Why?
|
| Particulate Matter | 19 | 2025 | 75 | 3.710 |
Why?
|
| Environmental Exposure | 21 | 2024 | 211 | 3.590 |
Why?
|
| Occupational Exposure | 27 | 2022 | 126 | 3.390 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 86 | 3.180 |
Why?
|
| Metals, Heavy | 3 | 2021 | 22 | 1.880 |
Why?
|
| Texas | 37 | 2025 | 3536 | 1.880 |
Why?
|
| Stillbirth | 3 | 2019 | 96 | 1.720 |
Why?
|
| Cyclonic Storms | 4 | 2021 | 76 | 1.620 |
Why?
|
| Metals | 4 | 2023 | 56 | 1.610 |
Why?
|
| Industry | 10 | 2021 | 29 | 1.600 |
Why?
|
| Arsenic | 4 | 2023 | 36 | 1.490 |
Why?
|
| Community-Based Participatory Research | 2 | 2023 | 59 | 1.420 |
Why?
|
| Residence Characteristics | 6 | 2020 | 269 | 1.420 |
Why?
|
| Disasters | 3 | 2021 | 100 | 1.370 |
Why?
|
| Mexican Americans | 6 | 2018 | 164 | 1.290 |
Why?
|
| Environmental Pollutants | 6 | 2018 | 72 | 1.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2024 | 229 | 1.260 |
Why?
|
| Premature Birth | 5 | 2018 | 415 | 1.250 |
Why?
|
| Ozone | 3 | 2019 | 19 | 1.180 |
Why?
|
| Stress, Psychological | 6 | 2021 | 545 | 1.130 |
Why?
|
| Oil and Gas Industry | 2 | 2018 | 5 | 1.110 |
Why?
|
| Pregnancy | 32 | 2025 | 7391 | 1.090 |
Why?
|
| Environmental Health | 3 | 2023 | 19 | 0.990 |
Why?
|
| Recycling | 2 | 2020 | 5 | 0.820 |
Why?
|
| Nitrogen Dioxide | 6 | 2022 | 15 | 0.820 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 7 | 2022 | 67 | 0.740 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.730 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 11 | 0.720 |
Why?
|
| Adult | 46 | 2025 | 30262 | 0.700 |
Why?
|
| Deer | 1 | 2021 | 14 | 0.690 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 142 | 0.680 |
Why?
|
| Population Dynamics | 2 | 2019 | 30 | 0.680 |
Why?
|
| Disaster Planning | 1 | 2021 | 61 | 0.670 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 623 | 0.660 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 17 | 0.650 |
Why?
|
| Fires | 1 | 2020 | 9 | 0.640 |
Why?
|
| Benzene | 7 | 2020 | 24 | 0.630 |
Why?
|
| Humans | 97 | 2025 | 125950 | 0.630 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 14 | 0.620 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 108 | 0.580 |
Why?
|
| Temperature | 1 | 2019 | 285 | 0.580 |
Why?
|
| Young Adult | 23 | 2023 | 9596 | 0.570 |
Why?
|
| Natural Gas | 1 | 2018 | 5 | 0.570 |
Why?
|
| Female | 65 | 2025 | 67908 | 0.560 |
Why?
|
| Logistic Models | 14 | 2019 | 1738 | 0.550 |
Why?
|
| Trace Elements | 1 | 2017 | 21 | 0.520 |
Why?
|
| Urban Population | 6 | 2019 | 235 | 0.500 |
Why?
|
| Butadienes | 1 | 2016 | 22 | 0.500 |
Why?
|
| Hazardous Substances | 5 | 2015 | 17 | 0.500 |
Why?
|
| Leukemia | 1 | 2019 | 354 | 0.490 |
Why?
|
| Social Class | 2 | 2017 | 198 | 0.480 |
Why?
|
| Multilingualism | 1 | 2015 | 35 | 0.470 |
Why?
|
| Community Participation | 1 | 2015 | 40 | 0.470 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 621 | 0.460 |
Why?
|
| Inhalation Exposure | 5 | 2020 | 33 | 0.460 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 3887 | 0.450 |
Why?
|
| Hypertension | 3 | 2018 | 1281 | 0.450 |
Why?
|
| Air Pollutants, Occupational | 7 | 2006 | 17 | 0.440 |
Why?
|
| Models, Theoretical | 7 | 2015 | 356 | 0.430 |
Why?
|
| Case-Control Studies | 12 | 2019 | 3297 | 0.420 |
Why?
|
| Occupational Diseases | 6 | 2016 | 75 | 0.420 |
Why?
|
| Pilot Projects | 5 | 2020 | 1383 | 0.420 |
Why?
|
| Risk Assessment | 7 | 2021 | 3417 | 0.390 |
Why?
|
| Birth Certificates | 3 | 2019 | 13 | 0.380 |
Why?
|
| Birth Weight | 5 | 2025 | 342 | 0.370 |
Why?
|
| Cohort Studies | 12 | 2022 | 4892 | 0.370 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 53 | 0.360 |
Why?
|
| Linear Models | 7 | 2017 | 672 | 0.350 |
Why?
|
| Legionellosis | 1 | 2011 | 4 | 0.350 |
Why?
|
| Water Supply | 2 | 2004 | 25 | 0.350 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 786 | 0.350 |
Why?
|
| Mercury | 2 | 2001 | 27 | 0.350 |
Why?
|
| Infant, Newborn | 15 | 2025 | 8374 | 0.350 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 867 | 0.350 |
Why?
|
| Water Pollutants, Chemical | 2 | 2004 | 36 | 0.340 |
Why?
|
| Asthma | 7 | 2014 | 760 | 0.340 |
Why?
|
| Nickel | 2 | 2001 | 21 | 0.330 |
Why?
|
| Cities | 2 | 2020 | 47 | 0.320 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 5 | 0.310 |
Why?
|
| Particle Size | 4 | 2022 | 131 | 0.310 |
Why?
|
| Odds Ratio | 10 | 2016 | 1187 | 0.310 |
Why?
|
| Gestational Age | 5 | 2022 | 1205 | 0.300 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 307 | 0.300 |
Why?
|
| Respiratory Tract Diseases | 3 | 2020 | 79 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2013 | 542 | 0.300 |
Why?
|
| Disinfection | 2 | 2011 | 24 | 0.300 |
Why?
|
| Agriculture | 2 | 2006 | 31 | 0.300 |
Why?
|
| Models, Statistical | 6 | 2017 | 465 | 0.300 |
Why?
|
| Risk Factors | 17 | 2019 | 10355 | 0.290 |
Why?
|
| Pesticides | 3 | 2022 | 28 | 0.290 |
Why?
|
| Bayes Theorem | 6 | 2024 | 285 | 0.290 |
Why?
|
| Male | 38 | 2023 | 62094 | 0.270 |
Why?
|
| Mining | 4 | 2010 | 7 | 0.270 |
Why?
|
| Metallurgy | 4 | 2000 | 6 | 0.260 |
Why?
|
| United States | 24 | 2019 | 11159 | 0.260 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.260 |
Why?
|
| Aerosols | 3 | 2022 | 60 | 0.250 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 12 | 0.250 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 58 | 0.240 |
Why?
|
| Biomarkers | 6 | 2017 | 3143 | 0.240 |
Why?
|
| Prevalence | 11 | 2018 | 2566 | 0.240 |
Why?
|
| Styrene | 4 | 2001 | 4 | 0.220 |
Why?
|
| Chemical Industry | 4 | 2001 | 7 | 0.220 |
Why?
|
| SEER Program | 3 | 2014 | 200 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1751 | 0.220 |
Why?
|
| Risk | 3 | 2019 | 722 | 0.220 |
Why?
|
| Trihalomethanes | 1 | 2004 | 5 | 0.210 |
Why?
|
| Cleft Lip | 2 | 2017 | 187 | 0.200 |
Why?
|
| United States Environmental Protection Agency | 3 | 2019 | 7 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2004 | 1166 | 0.200 |
Why?
|
| Cleft Palate | 2 | 2017 | 214 | 0.200 |
Why?
|
| Data Collection | 4 | 2023 | 368 | 0.200 |
Why?
|
| Cobalt | 1 | 2022 | 16 | 0.190 |
Why?
|
| Tungsten | 1 | 2022 | 3 | 0.190 |
Why?
|
| Health Surveys | 3 | 2020 | 245 | 0.190 |
Why?
|
| Middle Aged | 20 | 2021 | 27337 | 0.190 |
Why?
|
| Child | 10 | 2024 | 25070 | 0.180 |
Why?
|
| Glyoxylates | 1 | 2001 | 4 | 0.180 |
Why?
|
| Mandelic Acids | 1 | 2001 | 6 | 0.180 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 139 | 0.180 |
Why?
|
| Toluene | 3 | 2010 | 10 | 0.180 |
Why?
|
| Xylenes | 3 | 2010 | 13 | 0.180 |
Why?
|
| Benzene Derivatives | 3 | 2010 | 17 | 0.180 |
Why?
|
| Soil | 1 | 2021 | 73 | 0.170 |
Why?
|
| China | 1 | 2021 | 274 | 0.170 |
Why?
|
| Floods | 1 | 2021 | 18 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 231 | 0.170 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 8 | 0.170 |
Why?
|
| Exercise | 2 | 2017 | 833 | 0.170 |
Why?
|
| Women, Working | 2 | 2017 | 8 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 2865 | 0.170 |
Why?
|
| Spinal Dysraphism | 3 | 2015 | 273 | 0.160 |
Why?
|
| Cadmium | 1 | 2020 | 28 | 0.160 |
Why?
|
| Food Contamination | 3 | 2007 | 27 | 0.160 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.160 |
Why?
|
| Vehicle Emissions | 2 | 2022 | 20 | 0.160 |
Why?
|
| Aged | 14 | 2021 | 20039 | 0.160 |
Why?
|
| Feasibility Studies | 4 | 2017 | 788 | 0.160 |
Why?
|
| Styrenes | 3 | 1996 | 6 | 0.160 |
Why?
|
| Weather | 1 | 2019 | 14 | 0.160 |
Why?
|
| Regression Analysis | 5 | 2014 | 761 | 0.150 |
Why?
|
| RNA, Viral | 1 | 2021 | 511 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 120 | 0.150 |
Why?
|
| Urban Health | 1 | 2019 | 74 | 0.150 |
Why?
|
| Child, Preschool | 8 | 2024 | 14350 | 0.150 |
Why?
|
| Oil and Gas Fields | 1 | 2019 | 9 | 0.150 |
Why?
|
| Sister Chromatid Exchange | 2 | 1996 | 14 | 0.150 |
Why?
|
| Adolescent | 13 | 2021 | 19942 | 0.150 |
Why?
|
| Registries | 3 | 2019 | 1473 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 192 | 0.140 |
Why?
|
| Analysis of Variance | 5 | 2001 | 950 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1392 | 0.140 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 324 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 1998 | 9 | 0.140 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 39 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2035 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 17 | 0.140 |
Why?
|
| Occupations | 1 | 2017 | 18 | 0.130 |
Why?
|
| Fluorocarbons | 1 | 2017 | 53 | 0.130 |
Why?
|
| Workplace | 2 | 2015 | 74 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2025 | 16782 | 0.130 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 19 | 0.130 |
Why?
|
| Fetal Development | 3 | 2022 | 126 | 0.130 |
Why?
|
| Molecular Weight | 1 | 2017 | 298 | 0.130 |
Why?
|
| DNA Adducts | 1 | 1996 | 71 | 0.130 |
Why?
|
| Neural Tube Defects | 2 | 2010 | 362 | 0.130 |
Why?
|
| Serum Albumin | 1 | 1996 | 108 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2016 | 7 | 0.120 |
Why?
|
| Reproductive History | 1 | 1995 | 10 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1132 | 0.120 |
Why?
|
| Lead | 1 | 1995 | 24 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 28 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 70 | 0.110 |
Why?
|
| Cause of Death | 2 | 2014 | 466 | 0.110 |
Why?
|
| Publications | 1 | 2015 | 35 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 6579 | 0.110 |
Why?
|
| Menopause | 1 | 1995 | 83 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2016 | 179 | 0.110 |
Why?
|
| Chlamydia trachomatis | 1 | 2014 | 27 | 0.110 |
Why?
|
| Cross-Sectional Studies | 7 | 2016 | 3653 | 0.110 |
Why?
|
| Focus Groups | 1 | 2015 | 211 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 963 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 504 | 0.110 |
Why?
|
| Occupational Health | 3 | 2010 | 46 | 0.110 |
Why?
|
| Azithromycin | 1 | 2014 | 42 | 0.110 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 49 | 0.110 |
Why?
|
| Nutrition Surveys | 5 | 2016 | 292 | 0.110 |
Why?
|
| Juvenile Delinquency | 1 | 2014 | 25 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 173 | 0.110 |
Why?
|
| Prisoners | 1 | 2014 | 38 | 0.110 |
Why?
|
| Environment Design | 1 | 2014 | 17 | 0.110 |
Why?
|
| North America | 3 | 2000 | 248 | 0.110 |
Why?
|
| Smoking | 3 | 1996 | 894 | 0.110 |
Why?
|
| Doxycycline | 1 | 2014 | 119 | 0.110 |
Why?
|
| Iron | 1 | 2017 | 295 | 0.100 |
Why?
|
| Europe | 3 | 2000 | 353 | 0.100 |
Why?
|
| Uncertainty | 1 | 2014 | 94 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2016 | 193 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1347 | 0.100 |
Why?
|
| Population Surveillance | 3 | 2012 | 395 | 0.100 |
Why?
|
| Poverty | 2 | 2015 | 428 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2015 | 138 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 2012 | 7 | 0.100 |
Why?
|
| Infant | 7 | 2024 | 12782 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 336 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2012 | 42 | 0.100 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2003 | 15 | 0.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 2002 | 0.090 |
Why?
|
| Iron, Dietary | 1 | 2012 | 14 | 0.090 |
Why?
|
| Maintenance | 1 | 2011 | 1 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 39 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 121 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 386 | 0.090 |
Why?
|
| Health Personnel | 2 | 2006 | 527 | 0.090 |
Why?
|
| Gastroschisis | 1 | 2012 | 58 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 33185 | 0.090 |
Why?
|
| Age Factors | 4 | 2015 | 2762 | 0.090 |
Why?
|
| Equipment Contamination | 1 | 2011 | 40 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 537 | 0.080 |
Why?
|
| Time Factors | 5 | 2001 | 6025 | 0.080 |
Why?
|
| Demography | 3 | 2007 | 236 | 0.080 |
Why?
|
| Anencephaly | 1 | 2010 | 11 | 0.080 |
Why?
|
| Gasoline | 2 | 2022 | 3 | 0.080 |
Why?
|
| Parity | 2 | 2007 | 81 | 0.080 |
Why?
|
| Creatinine | 2 | 2001 | 360 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2014 | 822 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2022 | 6167 | 0.070 |
Why?
|
| Research Design | 2 | 2007 | 686 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5089 | 0.070 |
Why?
|
| Manufactured Materials | 2 | 1998 | 2 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2003 | 1421 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 346 | 0.070 |
Why?
|
| Dementia | 1 | 2013 | 411 | 0.070 |
Why?
|
| Incidence | 4 | 2023 | 3192 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 425 | 0.070 |
Why?
|
| Japan | 2 | 1998 | 171 | 0.070 |
Why?
|
| Cognition | 2 | 2024 | 782 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2838 | 0.070 |
Why?
|
| Michigan | 1 | 2007 | 45 | 0.070 |
Why?
|
| South Carolina | 1 | 2006 | 8 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 1099 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 998 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 418 | 0.050 |
Why?
|
| Chlorine | 1 | 2004 | 15 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1431 | 0.050 |
Why?
|
| Disinfectants | 1 | 2004 | 29 | 0.050 |
Why?
|
| Water Purification | 1 | 2004 | 19 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2011 | 938 | 0.050 |
Why?
|
| Fishes | 1 | 2003 | 30 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2508 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1486 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2010 | 258 | 0.050 |
Why?
|
| Alloys | 1 | 2022 | 14 | 0.050 |
Why?
|
| Antimony | 1 | 2022 | 10 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2025 | 254 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2022 | 71 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 220 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 43 | 0.050 |
Why?
|
| Seasons | 1 | 2004 | 309 | 0.050 |
Why?
|
| Maximum Allowable Concentration | 1 | 2001 | 6 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2023 | 305 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2001 | 16 | 0.040 |
Why?
|
| Transients and Migrants | 1 | 2001 | 28 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2001 | 73 | 0.040 |
Why?
|
| Italy | 1 | 2001 | 133 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 78 | 0.040 |
Why?
|
| Sociological Factors | 1 | 2021 | 9 | 0.040 |
Why?
|
| Medicaid | 2 | 2014 | 240 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1838 | 0.040 |
Why?
|
| Western Australia | 1 | 2000 | 4 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 31 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 457 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 409 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2010 | 1640 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1292 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 1998 | 19 | 0.040 |
Why?
|
| Baths | 1 | 1998 | 15 | 0.030 |
Why?
|
| Norway | 1 | 2017 | 29 | 0.030 |
Why?
|
| Menstruation | 1 | 2017 | 26 | 0.030 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 16 | 0.030 |
Why?
|
| Biotransformation | 1 | 1996 | 54 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 602 | 0.030 |
Why?
|
| Employment | 1 | 2017 | 66 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 96 | 0.030 |
Why?
|
| Time | 1 | 1996 | 93 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 231 | 0.030 |
Why?
|
| Bias | 1 | 1996 | 135 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 64 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 62 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 191 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 147 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 31 | 0.030 |
Why?
|
| Posture | 1 | 2015 | 133 | 0.030 |
Why?
|
| Income | 1 | 1995 | 129 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 139 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 40 | 0.030 |
Why?
|
| Food-Processing Industry | 1 | 1993 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 665 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 188 | 0.020 |
Why?
|
| Public Health | 1 | 2015 | 269 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 387 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1350 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 57 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 661 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 44 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 61 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 376 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 58 | 0.020 |
Why?
|
| Heme | 1 | 2012 | 52 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 276 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 448 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1430 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1474 | 0.020 |
Why?
|
| Job Description | 1 | 2010 | 8 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 82 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 398 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 61 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 1349 | 0.020 |
Why?
|
| Construction Materials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1343 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 429 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 358 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 781 | 0.020 |
Why?
|
| Life Style | 2 | 2003 | 430 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1522 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 530 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 802 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 276 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12352 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2053 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 437 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 808 | 0.020 |
Why?
|
| Great Lakes Region | 1 | 2003 | 1 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4305 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 171 | 0.010 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 1997 | 3 | 0.010 |
Why?
|
| Ventilation | 1 | 1993 | 5 | 0.010 |
Why?
|
| Netherlands | 1 | 1993 | 45 | 0.010 |
Why?
|
| United Kingdom | 1 | 1993 | 231 | 0.010 |
Why?
|
| Models, Biological | 1 | 1993 | 1374 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1990 | 354 | 0.000 |
Why?
|